Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:22:22.714Z.
Calculation as of: 2026-10-06T17:22:22.714Z.
Quote observation: 2026-10-06T17:20:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fa669979e2b3f995ef920df13c3a539cab2f3704a4556e475e3dd75e53b0e3a2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Kestra Medical Technologies, Ltd.
Market Cap
$1.60B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.61B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.59B
Free Cash Flow Yield
8.87%
TTM Avg
6.29%
3Y Avg
8.24%
5Y Avg
5.79%
Market Cap
$1.62B
Free Cash Flow Yield
N/A
TTM Avg
7.59%
3Y Avg
6.29%
5Y Avg
6.29%
Market Cap
$1.64B
Free Cash Flow Yield
0.25%
TTM Avg
0.34%
3Y Avg
0.34%
5Y Avg
0.34%
Market Cap
$1.54B
Free Cash Flow Yield
12.19%
TTM Avg
10.90%
3Y Avg
11.74%
5Y Avg
15.73%
Market Cap
$1.54B
Free Cash Flow Yield
N/A
TTM Avg
1.93%
3Y Avg
1.93%
5Y Avg
1.93%
Market Cap
$1.53B
Free Cash Flow Yield
N/A
TTM Avg
4.97%
3Y Avg
4.97%
5Y Avg
4.97%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kestra Medical Technologies, Ltd. (KMTS) | $1.60B | N/A | N/A | N/A | N/A |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | N/A | N/A | N/A | N/A |
| Omnicell, Inc. (OMCL)vs › | $1.59B | 8.87% | 6.29% | 8.24% | 5.79% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | N/A | 7.59% | 6.29% | 6.29% |
| Septerna Inc (SEPN)vs › | $1.63B | 6.45% | 8.06% | 8.06% | 8.06% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.64B | 0.25% | 0.34% | 0.34% | 0.34% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 12.19% | 10.90% | 11.74% | 15.73% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | N/A | 1.93% | 1.93% | 1.93% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.53B | N/A | 4.97% | 4.97% | 4.97% |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 17.93% | 21.87% | 15.34% | 11.00% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
